Thema
1339-63-5
2
3-(2-((phenylamino)carbonyl)ethenyl)-4,6-dichloroindole-2-carboxylic acid
1
5Q7ZVV76EI
8
9LSH52S3LQ
1
Adrenergic beta-Antagonists
1
Angiotensin Receptor Antagonists
1
Angiotensin-Converting Enzyme Inhibitors
1
Anticoagulants
8
Antioxidants
1
Aspirin
8
Beta-blocker
1
Klinische Studie
2
Clinical Trial, Phase II
3
Clinical Trial, Phase III
1
Clinical trial
1
Coenzymes
1
Comparative Study
3
Cyclooxygenase Inhibitors
1
Deoxyribonucleosides
1
Dichloroacetate
1
Dichloroacetic Acid
1
EC 2.7.1.-
2
EC 2.7.1.21
2
EC 3.4.21.68
1
EJ27X76M46
2
Echocardiography
1
Fibrinolytic Agents
2
Glycine Agents
1
Heart failure
2
Heart failure with reduced ejection fraction
1
Implantable cardioverter-defibrillator
1
Indoles
1
Ischemic stroke
1
Journal Article
17
Left atrium
1
Mitochondrial Proteins
1
Multicenter Study
Non-ischaemic cardiomyopathy
1
Observer-reported outcome measure
1
Placebos
1
Platelet Aggregation Inhibitors
6
Propensity score matching
1
Pyruvate dehydrogenase complex
1
R16CO5Y76E
8
Randomized Controlled Trial
14
Rare disease
1
Research Support, N.I.H., Extramural
14
Research Support, Non-U.S. Gov't
5
Research Support, U.S. Gov't, Non-P.H.S.
1
Research Support, U.S. Gov't, P.H.S.
1
mehr ...